India’s IPO market is again turning busy with Aditya Birla Sun Life AMC IPO schedule to open on 29 September for subscription. The offer, priced in the range of INR695 – 712 per share, aims to mobilize as much as INR2,768.26 crore by selling 38,880,000 shares. All the shares will be offered by existing shareholders, valuing the firm at nearly INR20,505.6 crore at the upper end of the price band. Following the successful listings of HDFC AMC and Reliance Nippon AMC, investors will be surely looking positively to this IPO as well. This is also visible in the strong grey market premium the offer is commanding. Through Aditya Birla AMC IPO review, we try to find out if the company’s valuation leaves something on the table for investors.
Mumbai-based Glenmark Life Sciences plans to launch its IPO on 27 July for subscription. The company is a developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs). Here are 10 key things you need to know before investing in Glenmark Life IPO.
1 Offer Structure
Like most public offers this season, Glenmark Life IPO will involve issuance of new shares as well as a sale by existing shareholders. The company aims to raise INR1,060 crore by issuing fresh shares.
In addition, 63,00,000 shares will be sold by its promoter Glenmark Pharmaceuticals.
2 Offer Pricing
Glenmark Life Sciences has filed its Red Herring Prospectus (RHP) and has revealed offer pricing in the range of INR695 – 720 per share.
Gurugram based Sona BLW Precision Forgings – one of India’s leading mission-critical automotive systems and components manufacturers – is planning to launch its maiden public offer later this month. The company filed its draft red herring prospectus (DRHP) with SEBI in February 2021 and received approval in May 2021. Here are few key points you need to know about the company and its business.
#1 Fresh + OFS
Sona BLW Precision Forgings IPO will involve mobilization of INR6,000 crores. The IPO will consist of a fresh issue of equity shares worth INR300 crore and an offer for sale (OFS) amounting to INR5,700 crores by existing shareholders.The capital raised through fresh issues is proposed to be used for repayment/pre-payment of INR225 crores borrowings availed by the company and general corporate purposes.
#2 Capital Structure
Singapore VII Topco III is the major shareholder in the company with a 66.28% equity stake. Singapore VII Topco III is an affiliate of global private equity major Blackstone Group. The remaining stake is held by Sona Autocomp Holding Private Limited. Sona Autocomp is controlled by Sunjay Kapur who has vast experience in the automotive industry and also serves as the chairman of Sona BLW Precision Forgings.
Aurangabad-based Varroc Engineering plans to launch its IPO next week and has priced the offer in the range of INR965 – 967 per share. The IPO will involve sale of 20,221,730 shares through an Offer For Sale (OFS), amounting to INR1,955.4 crore at the upper end of the price end. Investors can place orders for minimum 15 shares and in multiples thereafter. All these shares of the auto component manufacturer will be sold by existing shareholders. While the positive response to recent IPOs of RITES Limited and Fine Organic Industries indicates the positive sentiment, it is better to check the fundamentals before committing your money and Varroc Engineering IPO review is a step in this direction.
All OFS
As mentioned above, all the shares sold in the IPO will be offered by existing shareholders and thus, the company will not get anything from IPO proceeds. Among the selling shareholders are Omega TC Holdings Pte Ltd, Tata Capital Financial Services Limited and promoter Tarang Jain.
Omega TC Holdings made an investment in the company in March 2014 which has resulted in its stake going up to 12.55%. The Singapore-based private equity firm plans to sell its entire shareholding of 16,917,130 shares. Similarly, Tata Capital Financial Services plans to sell its 1.15% equity stake or 1,552,040 shares. Tarang Jain, who currently owns 46.35% equity stake in the company, plans to offload 1,752,560 shares which will lead to his stake dropping to just above 45%.
Mumbai-based Glenmark Life Sciences plans to launch its IPO on 27 July for subscription. The company is a developer and manufacturer of select high value, non-commoditized active pharmaceutical ingredients (APIs). Here are 10 key things you need to know before investing in Glenmark Life IPO.
